Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy

Despite the remarkable successes of cancer immunotherapies, the majority of patients will experience only partial response followed by relapse of resistant tumors. While treatment resistance has frequently been attributed to clonal selection and immunoediting, comparisons of paired primary and relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutwillig, Amit, Santana-Magal, Nadine, Farhat-Younis, Leen, Rasoulouniriana, Diana, Madi, Asaf, Luxenburg, Chen, Cohen, Jonathan, Padmanabhan, Krishnanand, Shomron, Noam, Shapira, Guy, Gleiberman, Annette, Parikh, Roma, Levy, Carmit, Feinmesser, Meora, Hershkovitz, Dov, Zemser-Werner, Valentina, Zlotnik, Oran, Kroon, Sanne, Hardt, Wolf-Dietrich, Debets, Reno, Reticker-Flynn, Nathan Edward, Rider, Peleg, Carmi, Yaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489212/
https://www.ncbi.nlm.nih.gov/pubmed/36124553
http://dx.doi.org/10.7554/eLife.80315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489212/
https://www.ncbi.nlm.nih.gov/pubmed/36124553
http://dx.doi.org/10.7554/eLife.80315

Ejemplares similares